Dr Reddy's Laboratories gets USFDA tentative nod for twice-yearly HIV prevention injection

Dr Reddy’s has received USFDA tentative approval for its twice-yearly injectable lenacapavir for HIV prevention, with plans to make it available across 120 countries outside the US at $40 per person per year. Initial supplies are expected before the end of 2026, followed by broader availability in 2027.